CONVINCE: Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation

Sponsor
Clinical Research Centre, Malaysia (Other)
Overall Status
Completed
CT.gov ID
NCT05244356
Collaborator
Institute for Health Behavioral Research, Malaysia (Other), University of Malaya (Other), UNICEF Malaysia (Other), Ministry of Health, Malaysia (Other), London School of Economics and Political Science (Other)
5,784
1
14
1.3
4514.1

Study Details

Study Description

Brief Summary

This is a randomised controlled experiment in the form of a web based survey study which randomly exposes participants to different forms of public health messages, after which participants will be assessed on their intent to take up the COVID-19 vaccine, recommend the vaccine, and also willingness to propagate the exposed message.

Study Design

Study Type:
Interventional
Actual Enrollment :
5784 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Effective Public Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation: A Randomized Controlled Experiment
Actual Study Start Date :
Apr 29, 2021
Actual Primary Completion Date :
Jun 7, 2021
Actual Study Completion Date :
Jun 7, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Descriptive Norm (70%)

Intervention in the form of a message likened to a social media post. Composed of 3 parts: Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects) Message content describing that about 70% of Malaysians have expressed acceptance for the COVID-19 vaccine. Rally slogan: "It's safe and effective!"

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Descriptive Norm

Intervention in the form of a message likened to a social media post. Composed of 3 parts: Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects) Message content describing that the COVID-19 vaccine has been widely tested including with the elderly and people with existing health conditions, while subsequently highlighting that the vaccine was already received by millions worldwide. Rally slogan: "It's safe and effective!"

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Healthcare worker (HCW) recommendation

Intervention in the form of a message likened to a social media post. Composed of 3 parts: Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects) Message content highlights recommendation from Malaysian healthcare workers to get the vaccine, since majority of them has already received it, including the Malaysian Health Director General Rally slogan: "It's safe and effective!"

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Negative attribute framing

Intervention in the form of a message likened to a social media post. Composed of 3 parts: Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects) Message content describing the rate of side effects occurring with COVID-19 vaccination in a negative frame. Rally slogan: "It's safe and effective!"

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Positive attribute framing

Intervention in the form of a message likened to a social media post. Composed of 3 parts: Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects) Message content describing the rate of side effects occurring with COVID-19 vaccination in a positive frame. Rally slogan: "It's safe and effective!"

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Risky choice framing (Safety)

Intervention in the form of a message likened to a social media post. Composed of 3 parts: Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects) Message content describing a risky choice frame which compares the death rates occurring with COVID-19 vaccination versus contracting the virus itself. Rally slogan: "It's safe and effective!"

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Risky choice framing (Side effects)

Intervention in the form of a message likened to a social media post. Composed of 3 parts: Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects) Message content describing a risky choice frame that compares the incidence rates of blood clots occurring with COVID-19 vaccination versus contracting COVID-19. Rally slogan: "It's safe and effective!"

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Control message

Control message containing only rally slogan: "It's safe and effective!"

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Combination message: Descriptive Norm (70%) + Descriptive Norm

Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Combination message: Descriptive Norm (70%) + HCW recommendation

Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Combination message: Descriptive Norm (70%) + Negative attribute framing

Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Combination message: Descriptive Norm (70%) + Positive attribute framing

Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Combination message: Descriptive Norm (70%) + Risky choice framing (Safety)

Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Experimental: Combination message: Descriptive Norm (70%) + Risky choice framing (Side effects)

Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.

Behavioral: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Outcome Measures

Primary Outcome Measures

  1. Change in intent to accept the COVID-19 vaccine amongst the Malaysian adult population. [Immediately before and after message exposure during questionnaire administration.]

    Outcome measure was assessed using a questionnaire answered through a 4 point ordinal scale. Scale ranges from '"Definitely no", "Not sure, but probably no", "Not sure, but probably yes"to Definitely yes".

  2. Change in intent to recommend the COVID-19 vaccine to healthy adults. [Immediately before and after message exposure during questionnaire administration.]

    Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale. Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".

  3. Change in intent to recommend the COVID-19 vaccine to elderly. [Immediately before and after message exposure during questionnaire administration.]

    Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale. Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".

  4. Change in intent to recommend the COVID-19 vaccine to people with existing health conditions. [Immediately before and after message exposure during questionnaire administration.]

    Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale. Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".

  5. Intent to share message on social media platform. [Immediately after message exposure during questionnaire administration.]

    Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".

Secondary Outcome Measures

  1. Moderators of vaccination intent. [Immediately after message exposure during questionnaire administration.]

    Outcome measure assessed using a series of questions answered through a 5 point ordinal scale. Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".

  2. Reliability of various information sources about COVID-19. [Immediately after message exposure during questionnaire administration.]

    Outcome measure assessed using a questionnaire that list out various types of information sources and having participants to rate the reliability for each source using a 5 point ordinal scale. Scale ranges from "Strongly not reliable", "Not reliable, "Not sure", "Reliable", and "Strongly reliable".

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Willing and able to give informed consent for participation in the trial

  • Malaysian nationality.

  • Can understand either the English or Malay language.

  • Aged 18 years or above

Exclusion Criteria:
  • Received at least one COVID-19 vaccination dose

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute for Clinical Research, National Institutes of Health, Malaysia Shah Alam Selangor Malaysia 40170

Sponsors and Collaborators

  • Clinical Research Centre, Malaysia
  • Institute for Health Behavioral Research, Malaysia
  • University of Malaya
  • UNICEF Malaysia
  • Ministry of Health, Malaysia
  • London School of Economics and Political Science

Investigators

  • Principal Investigator: Yee Liang Hing, MSc., Clinical Research Centre, Malaysia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nicholas Hing Yee Liang, Researcher, Principle Investigator, Pharmacist, Clinical Research Centre, Malaysia
ClinicalTrials.gov Identifier:
NCT05244356
Other Study ID Numbers:
  • NMRR-21-26-58107
First Posted:
Feb 17, 2022
Last Update Posted:
Feb 17, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nicholas Hing Yee Liang, Researcher, Principle Investigator, Pharmacist, Clinical Research Centre, Malaysia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 17, 2022